Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1269
| Despition | Glial-Derived Neurotrophic Factor Mouse Recombinant |
| SIZE | 2 µg |
| Purity | > 98.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1178 | Recombinant Human CXCR4 Protein (Fc Tag) (AC1178) | 50 µg | inquiry |
| ACPP-1098 | Synthetic Nanodisc Human CD133 Protein (AC1098) | 10 µg | inquiry |
| ACPP-1486 | Rat VEGF C Protein (AC1486) | 2 µg | inquiry |
| ACPP-1036 | Recombinant Human ANGPTL7 Protein (6×His Tag) (AC1036) | 50 µg | inquiry |
| ACPP-1726 | Human Midkine Protein (AC1726) | 5 µg | inquiry |
| ACPP-1314 | Syndecan-1 Blocking Peptide (AC1314) | 250 µg | inquiry |
| ACPP-1211 | Beta crystallin S Blocking Peptide (AC1211) | 250 µg | inquiry |
| ACPP-1812 | Human IMPA1 Protein (AC1812) | 5 µg | inquiry |
| ACPP-1626 | Human SHC1 Protein (AC1626) | 5 µg | inquiry |
| ACPP-1225 | POMT1 Blocking Peptide (AC1225) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.